IDH1 and central nervous system cancer: IDH1 down-regulation during the early stages of skin tumorigenesis is strongly correlated with tumor promotion [28]; moreover, IDH1 mutations are frequently found in melanoma and various other cancers, including leukemia and glioma, and contribute to metastasis by altering cellular metabolism [29–31].